Related Experiment Videos
Fluoroquinolones in the elderly: safety considerations
1Institute of Clinical Pharmacology and Toxicology, Benjamin Franklin Medical Center, Freie Universität Berlin, Berlin, Germany. ralf.stahlmann@medizin.fu-berlin.de
Drugs & Aging
|March 19, 2003
Summary
Fluoroquinolones are generally well-tolerated for bacterial infections. Special considerations for elderly patients are necessary due to age-related physiological changes and potential central nervous system adverse effects.
Area of Science:
- Pharmacology
- Geriatric Medicine
- Infectious Diseases
Background:
- Fluoroquinolones are broad-spectrum antibiotics widely used for bacterial infections.
- Adverse effects in the elderly are not reported with increased frequency, but comparative tolerability data are limited.
- Age-related decline in renal function necessitates dosage adjustments for renally eliminated fluoroquinolones.
Purpose of the Study:
- To review the safety and tolerability of commonly used fluoroquinolones.
- To highlight specific considerations for fluoroquinolone use in the elderly population.
- To discuss potential adverse effects and risk factors associated with fluoroquinolone therapy.
Main Methods:
- Literature review of fluoroquinolone adverse effects.
- Analysis of age-related changes in drug metabolism and excretion.
- Identification of risk factors for specific fluoroquinolone toxicities.
Main Results:
- Gastrointestinal and hypersensitivity reactions are less common with fluoroquinolones compared to other antibacterials.
- Central nervous system adverse effects are a concern in the elderly and may be misattributed to age.
- Fluoroquinolones can prolong the QT interval and increase the risk of tendinitis and tendon rupture, particularly in older adults with comorbidities.
Conclusions:
- Fluoroquinolones are generally well-tolerated but require careful consideration of individual patient profiles.
- Dosage adjustments based on renal function, rather than age alone, are recommended.
- Close monitoring for CNS effects and tendon disorders is crucial in elderly patients receiving fluoroquinolones.